[CEO 메세지] 카티스템, 일본임상 3상 승인 – 메디포스트

.rs-layer.slidelink a div{--wpr-bg-ef4a9d97-b367-45a0-88bb-e98cb0472c55: url('https://www.medi-post.co.kr/wp-content/plugins/revslider/sr6/assets/assets/coloredbg.png');}.rs-layer.slidelink a span{--wpr-bg-6376d6a0-a9df-419f-8344-3b8d27457f0e: url('https://www.medi-post.co.kr/wp-content/plugins/revslider/sr6/assets/assets/coloredbg.png');}.rll-youtube-player .play{--wpr-bg-07cae6b2-e1eb-41fa-bed7-14d997b65973: url('https://www.medi-post.co.kr/wp-content/plugins/wp-rocket/assets/img/youtube.png');}